Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Lack of association between CD226 genetic variants and inflammatory demyelinating diseases in Korean population.
Goodbye to all that: a short history of CCSVI.
Open Ring Sign Diagnostic of Multiple Sclerosis in the Emergency Department.
Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria.
The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis.
Brain connexins in demyelinating diseases: Therapeutic potential of glial targets.
Pegylated interferons: a nurses' review of a novel multiple sclerosis therapy.
Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis (commentary).
Important role of mast cells in multiple sclerosis.
IL-17A and multiple sclerosis: signaling pathways, producing cells and target cells in the central nervous system.
Evaluating Neurocognitive Deficits in Patients with Multiple Sclerosis via a Brief Neuropsychological Approach.
Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis.
Experimental models of neuromyelitis optica: current status, challenges and future directions.
Therapeutic potential of cannabinoid medicines.
Subacute sclerosing panencephalitis presenting as neuromyelitis optica.
Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX3CR1).
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid and the diagnosis of multiple sclerosis.
Neuro-Behçet's disease, its mimickers and anti-TNF therapy: a case-based review.
IL-27-induced modulation of autoimmunity and its therapeutic potential.
A basic overview of multiple sclerosis immunopathology.
Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
Myeloid derived suppressor cells in inflammatory conditions of the central nervous system.
Association between functional CD24 polymorphisms and susceptibility to autoimmune diseases: A meta-analysis.
The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.
Pages
« first
‹ previous
…
442
443
444
445
446
447
448
449
450
…
next ›
last »